Osmotherapy in neurocritical care

Current Neurology and Neuroscience Reports

Volumn 7, Issue 6, 2007, Pages 513-521

  Bhardwaj, Anish ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; BETAMETHASONE; CORTICOSTEROID; FUROSEMIDE; GLUCOSE; GLYCEROL; HETASTARCH; MANNITOL; NITROGEN; OSMOTIC AGENT; POTASSIUM; POTASSIUM ION; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; SODIUM ION; UREA; WATER;

BLOOD BRAIN BARRIER; BLOOD RHEOLOGY; BRAIN BLOOD VESSEL; BRAIN EDEMA; CASE STUDY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG DOSE COMPARISON; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG PENETRATION; HEMOGLOBINURIA; HEMOLYSIS; HEMORRHAGIC SHOCK; HUMAN; HYPERKALEMIA; HYPEROSMOLAR COMA; HYPOTENSION; HYPOVOLEMIA; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRAVASCULAR HEMOLYSIS; KIDNEY FAILURE; LUNG EDEMA; MEDICAL RESEARCH; MEMBRANE PERMEABILITY; NAUSEA AND VOMITING; ONCOTIC PRESSURE; OSMOSIS; PHLEBITIS; RECOMMENDED DRUG DOSE; RESUSCITATION; REVIEW; SERUM OSMOLALITY; WATER TRANSPORT;

BODY WATER; BRAIN; BRAIN EDEMA; CRITICAL CARE; DIURETICS, OSMOTIC; HUMANS; INTRACRANIAL HYPERTENSION; MANNITOL; UREA; WATER-ELECTROLYTE BALANCE;

EID: 36048960445     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-007-0079-2     Document Type: Review

References (55)

1. Paczynski RP: Osmotherapy: basic concepts and controversies. Crit Care Clin 1997, 13:105-129.
2. Bhardwaj A, Ulatowski JA: Cerebral edema: hypertonic saline solutions. Curr Treat Options Neurol 1999, 1:179-188.
3. Qureshi AI, Suarez JI: Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000, 28:3301-3313.
4. Harukuni I, Kirsch JR, Bhardwaj A: Cerebral resuscitation: role of osmotherapy. J Anesth 2002, 16:229-237.
5. Bhardwaj A, Ulatowski JA: Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004, 10:126-131.
6. Ogden AT, Mayer SA, Connolly ES: Hyperosmolar agents in neurosurgical practice: the evolving role of hypertonic saline. Neurosurgery 2005, 57:207-215.
7. Raslan A, Bhardwaj A: Medical management of cerebral edema. Neurosurg Focus 2007, 22:E12.
8. Ziai WC, Toung TJ, Bhardwaj A: Hypertonic saline: first-line therapy or cerebral edema? J Neurol Sci 2007, 261:157-166.
9. Klatzo I: Neuropathological aspects of cerebral edema. J Neuropathol Exp Neurol 1967, 26:1-14.
10. Weed LH, McKibben PS: Experimental alteration of brain bulk. Am J Physiol 1919, 531-555.
11. Fermont-Smith F, Forbes HS: Intraocular and intracranial pressure: an experimental study. Arch Neurol Psychiatry 1927, 18:550-564.
12. Hughes J, Mudd S, Strecker EA: Reduction of elevated intracranial pressure by concentrated solutions of human lyophile serum. Arch Neurol Psych 1938, 12:1277-1287.
13. Javid M, Settlage P: Effect of urea on cerebrospinal fluid pressure in human subjects. JAMA 1956, 160:943-949.
14. Wise BL, Carter N: The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebrospinal fluid pressure. J Neurosurg 1962, 19:1038-1043.
15. Zornow MH: Hypertonic saline as a safe and efficacious treatment of intracranial hypertension. J Neurosurg Anesth 1996, 8:175-177.
16. Schell RM, Applegate RL II, Cole DJ: Salt, starch, and water on the brain. J Neurosurg Anesth 1996, 8:178-182.
17. Agre P, King LS, Yasui M, et al.: Aquaporin water channels-from atomic structure to clinical medicine. J Physiol 2002, 542:3-16.
18. Diringer MN, Zazulia AR: Osmotic therapy: fact and fiction. Neurocrit Care 2004, 1:219-233.
19. Gondim FA, Aiyagari V, Shackleford A, Diringer MN: Osmolality not predictive of mannitol-induced acute renal insufficiency. J Neurosurg 2005, 103:444-447.
20. Toung TJ, Chen CH, Lin C, Bhardwaj A: Osmotherapy with hypertonic saline attenuates water content in brain and extracerebral organs. Crit Care Med 2007, 35:526-531.
21. Cascino T, Baglivo J, Conti J, et al.: Quantitative CT assessment of furosemide- and mannitol-induced changes in brain water content. Neurology 1983, 33:898-903.
22. Cantore G, Guidetti B, Virno M: Oral glycerol for the reduction of intracranial pressure. J Neurosurg 1964, 21:278-283.
23. Brain Trauma Foundation, American Association of Neurological Surgeons, joint Section on Neurotrauma and Critical Care: Use of mannitol: Brain Trauma Foundation, The American Association of Neurological Surgeons, The Joint Section on Neurotrauma and Critical Care. J Neurotrauma 2000, 17:521-525.
24. Miller JD, Leech P: Effects of mannitol and steroid therapy on intracranial volume-pressure relationships in patients. J Neurosurg 1975, 42:274-281.
25. Cottrell JE, Robustelli A, Post K, et al.: Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes. Anesthesiology 1977, 47:28-30.
26. James HE, Langfitt TW, Kumar VS, et al.: Treatment of intracranial hypertension. Analysis of 105 consecutive, continous recordings of intracranial pressure. Acta Neurochirsurgica 1977, 36:189-200.
27. Marshall LF, Smith RW, Rauscher LA, et al.: Mannitol dose requirements in brain-injured patients. J Neurosurg 1978, 48:169-172.
28. Muizelaar JP, Lutz HA, Becker DP: Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984, 61:700-706.
29. Mendelow AD, Teasedale GM, Russell T, et al.: Effect of mannitol on cerebral blood flow and cerebral perfusion pressure in human head injury. J Neurosurg 1985, 63:43-48.
30. Smith HP, Kelly DL, McWhorter JM, et al.: Comparison of mannitol regimens in patients with severe head injury undergoing intracranial monitoring. J Neurosurg 1986, 65:820-824.
31. Fisher B, Thomas D, Peterson B: Hypertonic saline lowers raised intracranial pressure in children after head trauma. J Neurosurg Anesthesiol 1992, 4:4-10.
32. Yu YL, Kumana CR, Lauder IJ, et al.: Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 1992, 23:967-971.
33. Gemma M, Cozzi S, Tommasino C, et al.: 7.5% hypertonic saline versus 20% mannitol during elective neurosurgical supratentorial procedures. J Neurosurg Anesth 1997, 9:329-334.
34. Qureshi AI, Suarez JI, Bhardwaj A, et al.: Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain. Crit Care Med 1998, 26:440-446.
35. Suarez JI, Qureshi AI, Bhardwaj A, et al.: Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998, 26:1118-1122.
36. Shackford SR, Bourguignon PR, Wald SL, et al.: Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma 1998, 44:50-58.
37. Simma B, Burger R, Falk M, et al.: A prospective, randomized, and controlled study of fluid management in children with severe head injury: lactated Ringer's solution versus hypertonic saline. Crit Care Med 1998, 26:1265-1270.
38. Schwarz S, Schwab S, Bertram M, et al.: Effect of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998, 29:1550-1555.
39. Horn P, Munch E, Vajkoczy P, et al.: Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates. Neurol Res 1999, 21:758-764.
40. Bereczki D, Mihalka L, Szatmari S, et al.: Mannitol use in acute stroke: case fatality at 30 days and 1 year. Stroke 2003, 34:1730-1735.
41. Bensten G, Breivik H, Lundar T, Stubbaug A: Predictable reduction of intracranial hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in critically ill patients with subarachnoid hemorrhage. Acta Anaesthesiol Scand 2004, 48:1089-1095.
42. Ware ML, Nemani VM, Meeker M, et al.: Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study. Neurosurgery 2005, 7:727-736.
43. Wakai A, Roberts I, Schierhout G: Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev 2007, (1):CDO01049.
44. Kalita J, Misra UK, Ranjan P, et al.: Effect of mannitol on regional cerebral blood flow in patients with intracerebral hemorrhage. J Neurol Sci 2004, 224:19-22.
45. Misra UK, Kalita J, Ranjan P, Mandal SK: Mannitol in intracerebral hemorrhage: a randomized controlled study. J Neurol Sci 2005, 234:41-45.
46. Schwarz S, Georgiadis D, Aschoff A, Schwab S: Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002, 33:136-140.
47. Suarez JI, Qureshi AI, Parekh PD, et al.: Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage. J Neurosurg Anesthesiol 1999, 11:178-184.
48. Tseng MY, AI-Rawi PG, Pickard JD, et al.: Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage. Stroke 2003, 34:1389-1396.
49. Karnat P, Vats A, Gross M, et al.: Use of hypertonic saline for the treatment of altered mental status associated with diabetic ketoacidosis. Pediatr Crit Care Med 2003, 4:239-242.
50. Murphy N, Auzinger G, Bernel W, Wendon J: The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004, 39:464-470.
51. Qureshi AI, Wilson DA, Traystman RJ. Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline. Neurosurgery 1999, 44:1055-1063.
52. Toung TJ, Tyler B, Brem H, et al.: Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor. J Neurosurg Anesthesiol 2002, 14:187-193.
53. Manley GT, Fujimura M, Ma T, et al.: Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 2000, 6:159-163.
54. Amiry-Moghaddam M, Otsuka T, Hurn PD, et al.: An alpha-syntrophin-dependent pool of AQP4 in astroglial end-feet confers bidirectional water flow between blood and brain. Proc Natl Acad Sci U S A 2003, 100:2106-2111.
55. Chang Y, Chen TY, Chen CH, et al.: Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy. J Appl Physiol 2006, 100:1445-1451.